Comments
KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2019 ,inter alia, to consider and approve 1.To consider and approve the un-audited financial results of the company for the quarter ended December 31, 2018. 2.To consider the resignation of Mr. Shailesh Mirgal as a Chief Financial Officer of the Company. 3.To consider the appointment of CA Sujit Kumar Dash as a Chief Financial Officer of the Company. 4.To consider the appointment of M/s. Deep Shukla & Associates, Company Secretaries to conduct Secretarial Audit of the Company for financial year ended 31st March, 2019. 5.Any other matter with the permission of the chair.
Source : BSE - www.bseindia.com
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.